These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 16545342)

  • 41. PEP-1-metallothionein-III protein ameliorates the oxidative stress-induced neuronal cell death and brain ischemic insults.
    Sohn EJ; Kim DW; Kim MJ; Jeong HJ; Shin MJ; Ahn EH; Kwon SW; Kim YN; Kim DS; Han KH; Park J; Hwang HS; Eum WS; Choi SY
    Biochim Biophys Acta; 2012 Oct; 1820(10):1647-55. PubMed ID: 22743691
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insight into the mechanism of internalization of the cell-penetrating carrier peptide Pep-1 through conformational analysis.
    Deshayes S; Heitz A; Morris MC; Charnet P; Divita G; Heitz F
    Biochemistry; 2004 Feb; 43(6):1449-57. PubMed ID: 14769021
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The protective effect of PEP-1-SOD1 preconditioning on hypoxia/reoxygenation injury in cultured human umbilical vein endothelial cells].
    Wang JN; Ding P; Huang YZ; Luo LN; Guo LY; Kong X; Shao F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Aug; 35(8):750-6. PubMed ID: 17963638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral delivery of peptides and proteins using lipid-based drug delivery systems.
    Li P; Nielsen HM; Müllertz A
    Expert Opin Drug Deliv; 2012 Oct; 9(10):1289-304. PubMed ID: 22897647
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of protein transduction domains on intracellular delivery of macromolecules.
    Murriel CL; Dowdy SF
    Expert Opin Drug Deliv; 2006 Nov; 3(6):739-46. PubMed ID: 17076596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The protective effect of PEP-1-CAT fusion protein on hydrogen peroxide-induced oxidative stress injury in human umbilical vein endothelial cells].
    Yao LL; Wang JN; Huang YZ; Guo LY; Kong X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):932-8. PubMed ID: 17217725
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cell selectivity and mechanism of action of short antimicrobial peptides designed from the cell-penetrating peptide Pep-1.
    Zhu WL; Hahm KS; Shin SY
    J Pept Sci; 2009 Sep; 15(9):569-75. PubMed ID: 19455552
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pep-1 peptide-conjugated elastic liposomal formulation of taxifolin glycoside for the treatment of atopic dermatitis in NC/Nga mice.
    Kang MJ; Eum JY; Park SH; Kang MH; Park KH; Choi SE; Lee MW; Kang KH; Oh CH; Choi YW
    Int J Pharm; 2010 Dec; 402(1-2):198-204. PubMed ID: 20888893
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PEGylation, successful approach to drug delivery.
    Veronese FM; Pasut G
    Drug Discov Today; 2005 Nov; 10(21):1451-8. PubMed ID: 16243265
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Expression and purification of PEP-1-EGFP fusion protein and its transduction into human umbilical vein endothelial cells].
    Dong X; Wang JN; Huang YZ; Guo LY
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1114-7. PubMed ID: 16939896
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Down-regulation of MAPK/NF-κB signaling underlies anti-inflammatory response induced by transduced PEP-1-Prx2 proteins in LPS-induced Raw 264.7 and TPA-induced mouse ear edema model.
    Jeong HJ; Park M; Kim DW; Ryu EJ; In Yong J; Cha HJ; Kim SJ; Yeo HJ; Jeong JH; Kim DS; Kim HC; Shin EJ; Park EY; Park JH; Kwon HY; Park J; Eum WS; Choi SY
    Int Immunopharmacol; 2014 Dec; 23(2):426-33. PubMed ID: 25241246
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human PEP-1-ribosomal protein S3 protects against UV-induced skin cell death.
    Choi SH; Kim SY; An JJ; Lee SH; Kim DW; Ryu HJ; Lee NI; Yeo SI; Jang SH; Won MH; Kang TC; Kwon HJ; Cho SW; Kim J; Lee KS; Park J; Eum WS; Choi SY
    FEBS Lett; 2006 Dec; 580(30):6755-62. PubMed ID: 17140567
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Levosulpiride, (S)-(-)-5-Aminosulfonyl-N-[(1-ethyl-2-pyrrolidinyl) methyl]-2-methoxybenzamide, enhances the transduction efficiency of PEP-1-ribosomal protein S3 in vitro and in vivo.
    Ahn EH; Kim DW; Kim DS; Woo SJ; Kim HR; Kim J; Lim SS; Kang TC; Kim DJ; Suk KT; Park J; Luo Q; Eum WS; Hwang HS; Choi SY
    BMB Rep; 2011 May; 44(5):329-34. PubMed ID: 21615988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nanocarrier fabrication and macromolecule drug delivery: challenges and opportunities.
    Agrahari V; Agrahari V; Mitra AK
    Ther Deliv; 2016; 7(4):257-78. PubMed ID: 27010987
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of Nanotechnology in Delivery of Protein and Peptide Drugs.
    Patil S; Vhora I; Amrutiya J; Lalani R; Misra A
    Curr Pharm Des; 2015; 21(29):4155-73. PubMed ID: 26323432
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Approaches towards enhanced transepithelial drug delivery.
    Majumdar S; Mitra AK
    Discov Med; 2006 Dec; 6(36):229-33. PubMed ID: 17250788
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Peptide-based matrices as drug delivery vehicles.
    Ezzat K; El Andaloussi S; Abdo R; Langel U
    Curr Pharm Des; 2010; 16(9):1167-78. PubMed ID: 20030616
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A non-covalent peptide-based strategy for siRNA delivery.
    Crombez L; Divita G
    Methods Mol Biol; 2011; 683():349-60. PubMed ID: 21053142
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DepoFoam technology: a vehicle for controlled delivery of protein and peptide drugs.
    Ye Q; Asherman J; Stevenson M; Brownson E; Katre NV
    J Control Release; 2000 Feb; 64(1-3):155-66. PubMed ID: 10640654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cell-penetrating peptides for drug delivery across membrane barriers.
    Foged C; Nielsen HM
    Expert Opin Drug Deliv; 2008 Jan; 5(1):105-17. PubMed ID: 18095931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.